Optimising COVID-19 Vaccination Policy to Mitigate SARS-CoV-2 Transmission within Schools in Zimbabwe.
COVID-19
Zimbabwe
schools
vaccination
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
15 Dec 2021
15 Dec 2021
Historique:
received:
15
11
2021
revised:
07
12
2021
accepted:
09
12
2021
entrez:
28
12
2021
pubmed:
29
12
2021
medline:
29
12
2021
Statut:
epublish
Résumé
The COVID-19 pandemic has disrupted the learning of millions of children across the world. Since March 2020 when the first cases of COVID-19 were reported in Zimbabwe, the country, like many others, has gone through periods of closing and re-opening of schools as part of the national COVID-19 control and mitigation measures. Schools promote the social, mental, physical, and moral development of children. With this viewpoint, the authors argue that schools should not be closed to provide a measured and efficient response to the threats posed by the COVID-19 epidemic. Rather, infection prevention and control strategies, including vaccination of learners and teachers, and surveillance in schools should be heightened. The use of multiple prevention strategies discussed in this viewpoint has shown that when outbreaks in school settings are adequately managed, the transmission usually is low. The information presented here suggests that schools should remain open due to the preponderance of evidence indicating the overriding positive impacts of this policy on the health, development, and wellbeing of children.
Identifiants
pubmed: 34960227
pii: vaccines9121481
doi: 10.3390/vaccines9121481
pmc: PMC8709186
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Lancet Glob Health. 2021 Dec;9(12):e1624-e1625
pubmed: 34695370
Pan Afr Med J. 2020 Nov 25;37(Suppl 1):41
pubmed: 33552369
J Glob Health. 2021 Jul 17;11:05013
pubmed: 34326997
MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1600-1604
pubmed: 33119558
Public Health Pract (Oxf). 2021 Nov;2:100070
pubmed: 34173586
MMWR Morb Mortal Wkly Rep. 2021 Sep 10;70(36):1255-1260
pubmed: 34499627
Pan Afr Med J. 2021 Apr 07;38:336
pubmed: 34285758
Pan Afr Med J. 2020 Apr 30;35(Suppl 2):13
pubmed: 32528624
Public Health Pract (Oxf). 2021 Nov;2:100200
pubmed: 34632435
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130433
pubmed: 24821919
Vaccines (Basel). 2021 Mar 12;9(3):
pubmed: 33809002
S Afr Med J. 2021 Sep 02;111(9):13391
pubmed: 34949240
Pan Afr Med J. 2021 Sep 17;40:46
pubmed: 34795827
PLoS One. 2021 Jan 29;16(1):e0246326
pubmed: 33513204
IJID Reg. 2021 Dec;1:3-4
pubmed: 35721771
N Engl J Med. 2021 Sep 2;385(10):875-884
pubmed: 34233097
Clin Infect Dis. 2021 May 18;72(10):e667-e674
pubmed: 32865204
Disaster Med Public Health Prep. 2022 Oct;16(5):1739-1740
pubmed: 34517934
Addiction. 2022 Apr;117(4):1177-1178
pubmed: 34729833
Pan Afr Med J. 2021 Jun 15;39:125
pubmed: 34527141
Euro Surveill. 2020 Jul;25(29):
pubmed: 32720636
J Med Internet Res. 2020 Sep 1;22(9):e19338
pubmed: 32790642